Mobile health tools for the management of chronic respiratory diseases

Archive ouverte

Addolorato, Giovanni | Bataller, Ramon | Burra, Patrizia | Castera, Laurent | Cortez Pinto, Helena | Diehl, Anna Mae | Gao, Bin | Gilmore, Sir Ian | Hampe, Jochen | Jürgen, Rehm | Karin, Michael | Krag, Alexander | Leon, David | Leptak, Christopher | Louvet, Alexandre | Lucey, Michael | Mcclain, Craig | Nagy, Laura | Pageaux, Georges-Philippe | Sanyal, Arun | Schnabl, Bernd | Tiniakos, Dina | Trautwein, Christian | Tsukamoto, Hidekazu | Szabo, Gyongyi | Kamath, Patrick S. | Shah, Vijay H. | Thursz, Mark | Mathurin, Philippe

Edité par CCSD ; Wiley -

International audience. Background: The market of mobile health (mHealth) technology is rapidly evolving,making new mobile technologies potentially available for healthcare systems. Patientempowerment through self‐monitoring of symptoms, shared decision making withthe physician, and easily accessible education are important features extending thereach of mHealth technology beyond traditional care.Methods: Two digital distribution platforms (Apple App Store and Google PlayStore) were searched for currently available mobile applications (apps) for patientswith chronic respiratory diseases (CRDs). A new index (score ranging from 0 to 10)was developed to assess the potential of apps as a tool to empower patientsthrough mobile technology (based on self‐monitoring, personalized feedback, andpatient education app features).Results: One hundred and twelve apps were retained for analysis and could beclassified in 5 categories: Asthma (n = 71), COPD (n = 15), Asthma and COPD(n = 15), Rhinitis and Asthma (n = 5), and Rhinosinusitis (n = 6). Eighty percentwere developed by medical technology companies compared to 18% by medicaldoctors and 2% by pharmaceutical companies. Two‐thirds of apps allow diseaseself‐monitoring, whereas over half of apps provide patient feedback throughgraphs. Sixty percent of apps contain easily accessible patient education material.Only three percent of apps reach a score of ≥7 on the newly designed patientempowerment index.Conclusions: A variety of apps are available for patients with CRDs of which onlyfew were developed by or jointly with medical doctors. The majority of these appsinclude self‐monitoring tools, but only few also provide personalized feedback,which is needed to adopt these apps into daily care.

Consulter en ligne

Suggestions

Du même auteur

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Archive ouverte | Avila, Matias | CCSD

International audience. Alcohol-related liver disease (ALD), which includes a range of disorders of different severity and is one of the most prevalent types of liver disease worldwide, has recently regained increas...

A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Archive ouverte | Rinella, Mary | CCSD

International audience

Alcoholic liver disease.

Archive ouverte | Seitz Helmut, K | CCSD

International audience. Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide. ALD can progress from alcoholic fatty liver (AFL) to alcoholic steatohepatitis (ASH), which is c...

Chargement des enrichissements...